发明申请
US20150329555A1 SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL COMPOUNDS AS TARGETING AGENTS OF ASGPR
审中-公开
取代的6,8-二氧杂环戊烯[3.2.1]作为ASGPR的靶向剂的OCT-2,3-DIOL化合物
- 专利标题: SUBSTITUTED-6,8-DIOXABICYCLO[3.2.1]OCTANE-2,3-DIOL COMPOUNDS AS TARGETING AGENTS OF ASGPR
- 专利标题(中): 取代的6,8-二氧杂环戊烯[3.2.1]作为ASGPR的靶向剂的OCT-2,3-DIOL化合物
-
申请号: US14714484申请日: 2015-05-18
-
公开(公告)号: US20150329555A1公开(公告)日: 2015-11-19
- 发明人: Spiros Liras , Vincent Mascitti , Benjamin Thuma
- 申请人: Pfizer Inc.
- 申请人地址: US NY New York
- 专利权人: PFIZER INC.
- 当前专利权人: PFIZER INC.
- 当前专利权人地址: US NY New York
- 主分类号: C07D493/08
- IPC分类号: C07D493/08 ; C07D309/14
摘要:
Compounds of Formula (A) are described herein and the uses thereof for the treatment of diseases, conditions and/or disorders mediated by pharmaceutical compositions and the uses thereof as asialoglycoprotein receptor (ASGPR) targeting agents.